Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
about
Poly Cystic Ovarian Syndrome: An Updated OverviewMetformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysisChildhood obesity and its impact on the development of adolescent PCOS.Should all women with PCOS be treated for insulin resistance?Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guidelinePolycystic ovarian syndrome: diagnosis and management.In polycystic ovary syndrome, adrenal steroids are regulated differently in the morning versus in response to nutrient intake.Preteen insulin levels interact with caloric intake to predict increases in obesity at ages 18 to 19 years: a 10-year prospective study of black and white girlsIdentification and treatment of metabolic complications in pediatric obesity.Cognitive-behavioral therapy for physical and emotional disturbances in adolescents with polycystic ovary syndrome: a pilot study.Interventional studies for polycystic ovarian syndrome in children and adolescents.An evolving scientific basis for the prevention and treatment of pediatric obesityBody composition in adults with newly diagnosed type 2 diabetes: effects of metforminCurrent approaches to the diagnosis and treatment of polycystic ovarian syndrome in youthAssessing and treating insulin resistance in women with polycystic ovarian syndromePolycystic ovary syndrome in the pediatric populationState of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors.Insulin resistance in children: consensus, perspective, and future directions.Differences in stimulated androgen levels in black and white obese adolescent females.Pediatric obesity: parallels with addiction and treatment recommendationsEffect of raloxifene in human neurocysticercosisCardiometabolic aspects of the polycystic ovary syndrome.Pharmacotherapy for childhood obesity: present and future prospects.Impact of metformin monotherapy versus metformin with oestrogen-progesterone on lipids in adolescent girls with polycystic ovarian syndromeFetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome.Ontogeny of polycystic ovary syndrome and insulin resistance in utero and early childhoodNonhuman primates as models for human adrenal androgen production: function and dysfunction.Menstrual health and the metabolic syndrome in adolescents.Clinical features, investigations and management of adolescents with polycystic ovary syndromeMetformin Increases Cortisol Regeneration by 11βHSD1 in Obese Men With and Without Type 2 Diabetes Mellitus.Insulin and hyperandrogenism in women with polycystic ovary syndrome.Managing childhood overweight: behavior, family, pharmacology, and bariatric surgery interventions.Use of metformin in pediatric age.Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis.Metabolic and endocrine connections of 17-hydroxypregnenolone in polycystic ovary syndrome womenThe Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Metformin-diet ameliorates coronary heart disease risk factors and facilitates resumption of regular menses in adolescents with polycystic ovary syndrome.Progesterone Suppression of LH Pulse Frequency in Adolescent Girls with Hyperandrogenism: Effects of Metformin.
P2860
Q26752564-422F7A68-F9FF-4FD1-AF86-BF547FAAE67DQ28088433-01F76E57-5152-4629-83AE-316442A2B708Q30405587-8ABE6BD1-2392-45C9-A3D2-524A6FAC1C15Q30423117-419BB697-5E1D-46D5-9277-293BF58FE615Q33569169-C9C84D44-0432-4DB8-A464-CB7F08D1B79FQ33587845-B8FAE697-6A84-4B43-AA2B-B76653E6A14DQ33723471-9EF03E04-75A0-43E9-B0CE-3EF903E0C6F5Q33797004-176B52A5-14FF-40F3-B6B8-7B4B0183304FQ33798608-8ED5B5F6-83E9-4B0F-96C8-4CBAF85FB213Q33893011-2AAB489E-C753-45D4-A057-C8F66036D81BQ33988450-6C8CA3D0-7877-4B60-9C00-ECAC37E8572FQ33996662-854CA0F9-7504-4015-9E39-9A9B3C50FDD9Q34028763-963DAB7D-FF85-4C8B-961E-333F6D32DC35Q34157227-6E1FD886-7FC6-4D13-BFFE-EE4D8A9586D8Q34871227-B01820F2-66BF-4CD3-804D-0E214080B49BQ34878055-4EE2F4AC-EF6E-4EAD-8AB4-29E6A8341DB7Q35075035-A0D6131E-6FAF-447F-9E93-9E6B92C1470CQ35233754-55069B7F-E564-4DA3-9F27-B59F8B2D4AB5Q35468539-2B5C620F-075B-4753-B5CC-AF3671A29D50Q35505723-EDBF251D-F62E-4297-AE9B-59269B2A4E50Q35655899-CADFB8B1-C3C4-4E15-B1D5-B9A660566770Q35961441-B35109AA-CAE1-44B8-A8D3-826765BA9C26Q36070028-CDEDD220-9FFB-4845-B616-3CDACAE4B8BDQ36287892-4D5B02BA-7D98-48F3-B632-1056F20815B5Q36468087-7AE687C5-98E9-499B-AA22-E326EB9470D4Q36554670-5E138041-EBC1-4D4A-A412-680092A23ACEQ36865817-79B05478-5B66-4272-B0EF-062386097A02Q37067105-BF15FBBB-82F0-4881-9F39-26C19F2F2C81Q37122965-3B0435B3-F8A0-496D-912F-7B5CD3E92512Q37198401-943A704B-7263-4E76-AE97-B247D429DD7FQ37294042-631EECE9-0E9A-4E9F-8F75-D6FC9CBE75F7Q37314264-DE55AC08-5DC9-484E-8273-03FB12CA0A46Q37355746-9D3AA3E9-5C4F-4A42-8E37-1408F494CAF2Q37365169-61141493-2781-486A-BB42-BF5FC19D9127Q37848915-D5697375-EA6F-4C04-A76B-75D499C454CCQ38003834-4A35D4CB-F92E-4700-9279-EE2D0914D7EFQ38645798-D7F74013-6578-4DA7-81CE-B174E7EF6425Q41640666-134B2AA8-46C9-4B63-97FE-815895BDC3A2Q43229974-6B4F687C-680E-49AE-8109-C4EC795B9C0BQ45071712-53824E7B-31D6-4329-B93D-F6E52D705B2B
P2860
Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@en
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@nl
type
label
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@en
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@nl
prefLabel
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@en
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@nl
P2093
P921
P356
P1476
Metformin therapy in obese ado ...... nsulinemia/insulin resistance.
@en
P2093
Kapriel Danadian
Silva A Arslanian
Vered Lewy
P304
P356
10.1210/JC.87.4.1555
P407
P577
2002-04-01T00:00:00Z